The Cannabis Investing Podcast

Max Simon, a cannabis thought leader, founder and CEO of Green Flower Media joins Rena Sherbill to discuss our favorite green flower. We discuss improving quality of life through cannabis, the job growth in the industry, running cannabis companies like a CPG company and why 'what cannabis stock should I buy' isn't the right question. We also cover the power of education and destigmatizing the cannabis plant.Learn more about your ad choices. Visit megaphone.fm/adchoices

With only 2 states, AYR Strategies is a top 5 EBITDA company and from a profit margin perspective, second in the industry. We're now in cannabis 2.0 which means more discipline from companies and investors. The winners have access to capital, bit everyone else is excluded. Jon Sandelman, AYR's CEO, returns to the show discuss with Rena Sherbill why culture and vision matter and why you can't build a big business on a weak foundation. We also talk about the currency of current deals in the space, the death spiral of dilution, and CPG multiples.Learn more about your ad choices. Visit megaphone.fm/adchoices

Though much of the US and Canadian cannabis space is focused on the adult-use/rec market, Africa, Europe, and Asia (most of the world!) are more focused on the medical side and that's where the legal industry is being established. David Parry, CEO of Cannsun Medhel, joins the show to talk about the medical side of cannabis, and focusing on Asia, Europe and Africa. Learning from indigenous communities about complements to THC and CBD. Integrating business with community, righting social equity wrongs, sustainably using stalks and roots, pushing back against traditional pharma and building a good seed bank in Africa and Thailand.Learn more about your ad choices. Visit megaphone.fm/adchoices

Seeking Alpha authors discuss the importance of passing MORE Act, the fallacy of free cash flow in the cannabis industry, potential Green Thumb-Trulieve rumors, and the struggles of MSOs in generating profits without economies of scale.

Many companies try and get away from the stoner side of cannabis; Scott Sundvor and Space Coyote lean into it. Importance of being focused on profit from the beginning while respecting the plant and consumer. Many great companies have risen from great recessions. 2020 the year of survival. Thoughts on cultivation, natural selection in the cannabis space, getting away from venture dollars and learning the lessons of Covid. Favorite strains and joint rolling tips!Learn more about your ad choices. Visit megaphone.fm/adchoices

Trulieve recently reported earnings and is getting a lot of shareholder love - we take a deeper dive into the numbers in a frank conversation with CEO Kim Rivers. We talk growth despite onerous banking regulations, incremental momentum on 280E, why discipline matters and building a hub model across the US. We also discuss issuing debt and the salient lesson that capital markets aren't always available so can't rely on them to run your business.Learn more about your ad choices. Visit megaphone.fm/adchoices

Everyone agrees that cannabis in the 21st century is far different than cannabis of the past - much of that has to do with terpenes. Chris Campagna, CEO of True Terpenes, joins Rena Sherbill to discuss well, terpenes, and the entourage effect. We also cover taking a different approach to medicine than traditional pharma, the future of inter-state cannabis commerce - challenges of getting genetics from state to state when the plant is still illegal; evolution of testing, edibles and improving cannabis beverages.Learn more about your ad choices. Visit megaphone.fm/adchoices

We're in a small business crisis - now is the time to pick up distressed assets. Matt Hawkins, founder of Entourage Effect Capital, joins Rena Sherbill to discuss opportunities for distressed investing, why this time has been great for the cannabis industry and drifting towards real growth opportunities in edibles and liquids. We also talk legalization as the next big wave, why flower isn't going anywhere, creating scale with new investments, politicization of safe banking and toxic optimism.Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Ethan Russo and Dale Hunt explore the biochemical wonders of cannabis, highlighting endocannabinoids, the entourage effect, and the future of medicine. They discuss forming Breeder's Best, emphasizing the importance of breeders in the industry. The podcast delves into the diverse medicinal properties of cannabis, optimal growing practices, global regulations, and the versatility of cannabis in different climates.

Exploring more about the medical/pharma side of cannabis sector and thematic ETF investing. Rahul Bhushan is co-founder of Rize ETF and joins Rena Sherbill to discuss when passive makes more sense than active management, low fees and transparency. Europe's funds and cannabis market vs US and Canada, preferring CBD to THC, R&D of other cannabinoids, ancillary players and the 3 waves of the cannabis industry.Learn more about your ad choices. Visit megaphone.fm/adchoices